Brief: Acuvi AB Says To Discontinue Medical Technology Distribution Business In H2 2026
26/03/2026 16:59
March 26 (Reuters) - Acuvi AB ACUVI.ST: ACUVI AB - TO DISCONTINUE MEDICAL TECHNOLOGY DISTRIBUTION BUSINESS IN H2 2026 ACUVI AB - DISCONTINUATION ALIGNS WITH STRATEGIC FOCUS ON PROPRIETARY HIGH-MARGIN APPLICATIONS ACUVI AB - ACUVI ESTIMATES A NEGATIVE EBITDA IMPACT OF APPROXIMATELY SEK 4 MILLION IN 2026 ACUVI AB - TO CONTINUE DISTRIBUTION TO OTHER U.S. CUSTOMERS AND ENGAGEMENT WITH ROBOTICS CUSTOMER ACUVI AB - COMPANY INTENDS TO OFFSET THIS THROUGH INCREASED SALES OF ITS PROPRIETARY TECHNOLOGIES AND PRODUCTS. ACUVI AB: HAS SECURED SUPPLY TO FULFILL ALL EXISTING CUSTOMER ORDERS THROUGH AUGUST 21, 2026. Source text: ID:nWkr1fPJRW Further company coverage: ACUVI.ST ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acuvi AB
See all newsBrief: Acuvi Q1 EBIT Swings To Loss Of SEK 7.6 Million
Brief: Acuvi Receives Order From U.S.-Based Defense Customer
Brief: Acuvi Selected As Supplier To Formula 1 Team
Brief: Acuvi Gets $1.3 Mln Order From U.S. Based Defense Customer
Brief: Acuvi AB Says To Discontinue Medical Technology Distribution Business In H2 2026